Neumora Therapeutics, Inc.
Ticker: NMRA
| Insider | Title |
|---|---|
| Alaa Halawa | Director |
| Carol Y. Suh | Chief Operating Officer |
| Clinton Bybee | 10% or greater ownership |
| Daljit Singh Aurora | Chief Strategy Officer |
| David Piacquad | Director |
| Henry O Gosebruch | President CEO, Director |
| Jason Duncan | Chief Legal Officer |
| Joshua Pinto | Chief Financial Officer |
| Keith Crandell | 10% or greater ownership |
| Kristina Burow | Director, 10% or greater ownership |
| Matthew K Fust | Director |
| Maykin Ho | Director |
| Michael Lee Milligan | See Remarks |
| Paul L Berns | Director |
| Robert A. Lenz | Head of RD |
| Robert Nelsen | 10% or greater ownership |
| Steven Gillis | 10% or greater ownership |
| Venture Fund Vii, L.p. Arch | 10% or greater ownership |
| Venture Fund Viii Overage, L.p. Arch | 10% or greater ownership |
| Venture Fund X Overage, L.p. Arch | 10% or greater ownership |
| Venture Fund X, L.p. Arch | 10% or greater ownership |
| Venture Fund Xii, L.p. Arch | 10% or greater ownership |
| Venture Partners Vii, L.p. Arch | 10% or greater ownership |
| Venture Partners Vii, Llc Arch | 10% or greater ownership |
| Venture Partners Viii, Llc Arch | 10% or greater ownership |
| Venture Partners X Overage, L.p. Arch | 10% or greater ownership |
| Venture Partners X, L.p. Arch | 10% or greater ownership |
| Venture Partners X, Llc Arch | 10% or greater ownership |
| Venture Partners Xii, L.p. Arch | 10% or greater ownership |
| Venture Partners Xii, Llc Arch | 10% or greater ownership |